Suvac A, Ashton J, Bristow R
Nat Rev Cancer. 2025; 25(3):167-188.
PMID: 39875616
DOI: 10.1038/s41568-024-00781-9.
Celora G, Nixson R, Pitt-Francis J, Maini P, Byrne H
Bull Math Biol. 2024; 86(12):145.
PMID: 39503769
PMC: 11541430.
DOI: 10.1007/s11538-024-01359-0.
Yehuda R, Dromi I, Levin Y, Carell T, Geacintov N, Livneh Z
Oncogene. 2024; 44(1):42-49.
PMID: 39468223
PMC: 11700837.
DOI: 10.1038/s41388-024-03192-0.
Peppicelli S, Calorini L, Bianchini F, Papucci L, Magnelli L, Andreucci E
Cell Oncol (Dordr). 2024; 48(1):27-41.
PMID: 39023664
PMC: 11850579.
DOI: 10.1007/s13402-024-00969-z.
de Magalhaes C, Sandoval K, Kagan F, McCormack G, Schrama D, Carrilho R
PLoS One. 2024; 19(3):e0300472.
PMID: 38517901
PMC: 10959376.
DOI: 10.1371/journal.pone.0300472.
Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype.
Lee S, Pyo A, Koritzinsky M
Sci Adv. 2023; 9(47):eadj6409.
PMID: 37992163
PMC: 10664991.
DOI: 10.1126/sciadv.adj6409.
Phenotypic and Functional Diversity of Neutrophils in Gut Inflammation and Cancer.
Sumagin R
Am J Pathol. 2023; 194(1):2-12.
PMID: 37918801
PMC: 10768535.
DOI: 10.1016/j.ajpath.2023.10.009.
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation.
Geffen Y, Anand S, Akiyama Y, Yaron T, Song Y, Johnson J
Cell. 2023; 186(18):3945-3967.e26.
PMID: 37582358
PMC: 10680287.
DOI: 10.1016/j.cell.2023.07.013.
Chronic hypoxia is associated with transcriptomic reprogramming and increased genomic instability in cancer cells.
Abou Khouzam R, Sharda M, Rao S, Kyerewah-Kersi S, Zeinelabdin N, Mahmood A
Front Cell Dev Biol. 2023; 11:1095419.
PMID: 36968212
PMC: 10033758.
DOI: 10.3389/fcell.2023.1095419.
Claspin-Dependent and -Independent Chk1 Activation by a Panel of Biological Stresses.
Hsiao H, Yang C, Masai H
Biomolecules. 2023; 13(1).
PMID: 36671510
PMC: 9855620.
DOI: 10.3390/biom13010125.
Epigenetic Reprogramming of Kaposi's Sarcoma-Associated Herpesvirus during Hypoxic Reactivation.
Singh R, Bose D, Robertson E
Cancers (Basel). 2022; 14(21).
PMID: 36358814
PMC: 9654037.
DOI: 10.3390/cancers14215396.
RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
Tu Q, Liu X, Yao X, Li R, Liu G, Jiang H
J Exp Clin Cancer Res. 2022; 41(1):274.
PMID: 36109793
PMC: 9476698.
DOI: 10.1186/s13046-022-02490-3.
Neutrophils and micronuclei: An emerging link between genomic instability and cancer-driven inflammation.
Bui T, Sumagin R
Mutat Res. 2022; 824:111778.
PMID: 35334355
PMC: 9756381.
DOI: 10.1016/j.mrfmmm.2022.111778.
The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?.
Abou Khouzam R, Zaarour R, Brodaczewska K, Azakir B, Venkatesh G, Thiery J
Front Immunol. 2022; 13:828875.
PMID: 35211123
PMC: 8861358.
DOI: 10.3389/fimmu.2022.828875.
Cardiac ischemia on-a-chip to investigate cellular and molecular response of myocardial tissue under hypoxia.
Veldhuizen J, Chavan R, Moghadas B, Park J, Kodibagkar V, Migrino R
Biomaterials. 2022; 281:121336.
PMID: 35026670
PMC: 10440189.
DOI: 10.1016/j.biomaterials.2021.121336.
Differential Effects of Combined ATR/WEE1 Inhibition in Cancer Cells.
Rodland G, Hauge S, Hasvold G, Bay L, Raabe T, Joel M
Cancers (Basel). 2021; 13(15).
PMID: 34359691
PMC: 8345075.
DOI: 10.3390/cancers13153790.
PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage.
Su X, Wang J, Jiang L, Chen Y, Lu T, Mendonca M
Cancer Lett. 2021; 519:304-314.
PMID: 34329742
PMC: 8403654.
DOI: 10.1016/j.canlet.2021.07.040.
Hypoxia-induced SETX links replication stress with the unfolded protein response.
Ramachandran S, Ma T, Griffin J, Ng N, Foskolou I, Hwang M
Nat Commun. 2021; 12(1):3686.
PMID: 34140498
PMC: 8211819.
DOI: 10.1038/s41467-021-24066-z.
DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.
Rominiyi O, Collis S
Mol Oncol. 2021; 16(1):11-41.
PMID: 34036721
PMC: 8732357.
DOI: 10.1002/1878-0261.13020.
RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy.
Iqbal W, Demidova E, Serrao S, ValizadehAslani T, Rosen G, Arora S
Front Genet. 2021; 12:628758.
PMID: 33868369
PMC: 8045241.
DOI: 10.3389/fgene.2021.628758.